Quantum Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH1889637D
- Pages: 33
- November 2018
- Total Views:1126
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
Quantum Pharma Ltd (Quantum Pharma), a subsidiary Clinigen Group Plc, is a manufacturer and supplier of unlicensed medicines. The company develops, manufactures, and supplies niche pharmaceutical products. It offers dermatology products, branded generics and vitamins, borderline substances, short supply products, made-to-measure hosiery and dressings, coloplast ostomy products, veil cover cream, gluten-free breads, vennax, nabilone capsules, acetylcysteine, mediven stockings and jobst compression stockings. The company offers its products to retail pharmacy, pharmaceutical wholesaler, hospital, and homecare markets. Quantum Pharma is headquartered in Durham, the UK.
Quantum Pharma Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quantum Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Quantum Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Apax Partners to Acquire neuraxpharm Arzneimittel from Atax and Neuraxpharm 12
Licensing Agreements 13
Quantum Pharma Enters into Licensing Agreement with Moorfields Pharma 13
Quantum Pharma Enters into Licensing Agreement with Futura Medical 14
German Pharma Company Enters into Licensing Agreement with Colonis Pharma 15
Quantum Pharma Enters into Licensing Agreements 16
Equity Offering 17
Quantum Pharma to Raise USD18.43 Million in Private Placement of shares 17
Quantum Pharma Raises USD167 Million in IPO 18
Acquisition 19
NuPharm Acquires Laboratoire Biodim from Pharma Omnium International 19
Clinigen Acquires Quantum Pharma for USD199 Million 20
Quantum Pharma Acquires NuPharm 22
Quantum Pharma Acquires Lamda, Lamda Labs and Lamda Pharma for USD10.4 million 23
Quantum Pharma Ltd-Key Competitors 24
Quantum Pharma Ltd-Key Employees 25
Quantum Pharma Ltd-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 22, 2017: Quantum Pharma Announced Unaudited results for the half year ended 31 July 2017 27
May 03, 2017: Quantum Pharma Announces Final audited results for the year ended 31 January 2017 31
Other Significant Developments 32
Jun 26, 2017: Quantum Pharma: Disposal of Biodose Services and Trading Update 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List Of Figure
List of Figures
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Quantum Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quantum Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quantum Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Quantum Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Apax Partners to Acquire neuraxpharm Arzneimittel from Atax and Neuraxpharm 12
Quantum Pharma Enters into Licensing Agreement with Moorfields Pharma 13
Quantum Pharma Enters into Licensing Agreement with Futura Medical 14
German Pharma Company Enters into Licensing Agreement with Colonis Pharma 15
Quantum Pharma Enters into Licensing Agreements 16
Quantum Pharma to Raise USD18.43 Million in Private Placement of shares 17
Quantum Pharma Raises USD167 Million in IPO 18
NuPharm Acquires Laboratoire Biodim from Pharma Omnium International 19
Clinigen Acquires Quantum Pharma for USD199 Million 20
Quantum Pharma Acquires NuPharm 22
Quantum Pharma Acquires Lamda, Lamda Labs and Lamda Pharma for USD10.4 million 23
Quantum Pharma Ltd, Key Competitors 24
Quantum Pharma Ltd, Key Employees 25
Quantum Pharma Ltd, Subsidiaries 26
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Quantum Pharma Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Quantum Pharma Ltd (Quantum Pharma), a subsidiary Clinigen Group Plc, is a manufacturer and supplier of unlicensed medicines. The company develops, manufactures, and supplies niche pharmaceutical products. It offers dermatology products, branded generics and vitamins, borderline substances, short supply products, made-to-measure hosiery and dressings, coloplast ostomy products, veil cover cream, gluten-free breads, vennax, nabilone capsules, acetylcysteine, mediven stockings and jobst compression stockings. The company offers its products to retail pharmacy, pharmaceutical wholesaler, hospital, and homecare markets. Quantum Pharma is headquartered in Durham, the UK.
Quantum Pharma Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quantum Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Quantum Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Apax Partners to Acquire neuraxpharm Arzneimittel from Atax and Neuraxpharm 12
Licensing Agreements 13
Quantum Pharma Enters into Licensing Agreement with Moorfields Pharma 13
Quantum Pharma Enters into Licensing Agreement with Futura Medical 14
German Pharma Company Enters into Licensing Agreement with Colonis Pharma 15
Quantum Pharma Enters into Licensing Agreements 16
Equity Offering 17
Quantum Pharma to Raise USD18.43 Million in Private Placement of shares 17
Quantum Pharma Raises USD167 Million in IPO 18
Acquisition 19
NuPharm Acquires Laboratoire Biodim from Pharma Omnium International 19
Clinigen Acquires Quantum Pharma for USD199 Million 20
Quantum Pharma Acquires NuPharm 22
Quantum Pharma Acquires Lamda, Lamda Labs and Lamda Pharma for USD10.4 million 23
Quantum Pharma Ltd-Key Competitors 24
Quantum Pharma Ltd-Key Employees 25
Quantum Pharma Ltd-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 22, 2017: Quantum Pharma Announced Unaudited results for the half year ended 31 July 2017 27
May 03, 2017: Quantum Pharma Announces Final audited results for the year ended 31 January 2017 31
Other Significant Developments 32
Jun 26, 2017: Quantum Pharma: Disposal of Biodose Services and Trading Update 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List Of Figure
List of Figures
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Quantum Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quantum Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quantum Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Quantum Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Quantum Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Apax Partners to Acquire neuraxpharm Arzneimittel from Atax and Neuraxpharm 12
Quantum Pharma Enters into Licensing Agreement with Moorfields Pharma 13
Quantum Pharma Enters into Licensing Agreement with Futura Medical 14
German Pharma Company Enters into Licensing Agreement with Colonis Pharma 15
Quantum Pharma Enters into Licensing Agreements 16
Quantum Pharma to Raise USD18.43 Million in Private Placement of shares 17
Quantum Pharma Raises USD167 Million in IPO 18
NuPharm Acquires Laboratoire Biodim from Pharma Omnium International 19
Clinigen Acquires Quantum Pharma for USD199 Million 20
Quantum Pharma Acquires NuPharm 22
Quantum Pharma Acquires Lamda, Lamda Labs and Lamda Pharma for USD10.4 million 23
Quantum Pharma Ltd, Key Competitors 24
Quantum Pharma Ltd, Key Employees 25
Quantum Pharma Ltd, Subsidiaries 26
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Quantum Pharma Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 131 | 
November 2020
Page 95 | November 2020
Page 96 | August 2020
Page 101 | August 2020
Page 15 | July 2020